J.B. Chemicals & Pharmaceuticals Lt — Call Transcript 2022

Jul 29, 2022

==> picture [595 x 156] intentionally omitted <==

July 29, 2022

National Stock Exchange of India Limited Exchange Plaza, 5[th] Floor, Plot No. C/1, G-Block, Bandra Kurla Complex, Bandra (E), Mumbai – 400051.

Stock Symbol: JBCHEPHARM

Dear Sir,

Subject: Investors/analysts call with management

Ref.: Disclosure under regulation 30 of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015

Pursuant to Regulation 30 read with Schedule III of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015, this is to inform you that the Company has scheduled a conference call for investors and analysts on Friday, August 5, 2022 at 2.00 p.m. IST to discuss its results and developments for the first quarter ended June 30, 2022.

All interested investors/ analysts may join using the following dial-in numbers:

Universal Dial-in Number (India): +91 22 6280 1141/ +91 22 7115 8042

International Numbers

Hong Kong Local Access Number: 800 964 448 Singapore Local Access Number: 800 101 2045 UK Local Access Number: 0 808 101 1573

USA Local Access Number: 1 866 746 2133

==> picture [596 x 179] intentionally omitted <==

==> picture [595 x 156] intentionally omitted <==

The document containing the link for registration and log-in to join the said conference call is attached herewith. Alternatively, the investor/analysts can also log on to the Company’s website www.jbpharma.com to register and join the said conference call.

The schedule of the meeting may change due to exigencies.

We request you to take this on record.

Thanking you,

Yours faithfully,

For J.B. Chemicals & Pharmaceuticals Limited

Sandeep Anil Phadnis Digitally signed by Sandeep Anil Phadnis DN: c=IN, o=Personal, 2.5.4.20=3cf6eb0200f976a58369e39fde8b8876481484d38598145f6e21f446bb743f2e, postalCode=411038, st=Maharashtra, serialNumber=cc500fdd638e71336fc58b204e2ba05ea7c4ade49b8fe438e8f254c300dec735, cn=Sandeep Anil Phadnis Date: 2022.07.29 17:40:57 +05'30'

Sandeep Phadnis Vice President – Secretarial & Company Secretary

==> picture [596 x 179] intentionally omitted <==

==> picture [195 x 173] intentionally omitted <==

==> picture [104 x 115] intentionally omitted <==

JB Pharma Q1 FY23 Earnings Conference Call on Friday, August 05, 2022 at 2:00 PM IST

JB Pharma (J B Chemicals and Pharmaceuticals Ltd.), one of the fastest growing pharmaceutical companies in India, will host a conference call for investors and analysts on Friday, August 05, 2022 at 2:00 PM IST to discuss its results and developments for the first quarter ended 30[th] June, 2022. The financial results will be announced on the 04[th] of August, 2022.

The senior management of JB Pharma will be present to address the call.

Details of the conference call are as follows:

Timing	2:00-3:00 pm IST Friday, August 05, 2022
	To enable participants to connect to the conference call without having to
	wait for an operator, please register at the below mentioned link.
Pre-registration
	You will receive dial in numbers, passcode and a pin for the concall on the
	registered email address provided by you. Kindly dial into the call on the
	Conference Call date and use thepasscode &pin to connect to call.
Universal Dial-in Number (India)	+91 22 6280 1141 +91 22 7115 8042
Hong Kong Local Access Number	800 964 448
Singapore Local Access Number	800 101 2045
UK Local Access Number	0 808 101 1573
USA Local Access Number	1 866 746 2133

For further information please contact: Lakshay Kataria Jason D’Souza Siddharth Rangnekar Chief Financial Officer Vice President Shruti Joshi JB Pharma JB Pharma CDR India Tel: +91 22 2439 5200 / 2439 5500 Tel: +91 982 021 5005 Tel: +91 932 174 0537 / 750 656 7349 Email: lakshay.kataria@jbpharma.com Email: jason.dsouza@jbpharma.com Email: siddharth@cdr-india.com shruti@cdr-india.com

==> picture [138 x 72] intentionally omitted <==